Company’s AI-Powered Decisioning Platform recognized in the “AI Platform” category PARSIPPANY, N.J.–(BUSINESS WIRE)–#AI—Provenir, a global…
Manifest complete, flight hardware departs California for the first orbital launch from U.K. soil LONG…
Index compares 44 retirement income systems, covering 65 percent of the world’s population Index sees…
Dubai, United Arab Emirates–(Newsfile Corp. – October 10, 2022) – Rimaunangis Token ($RXT) was the…
DALLAS, TX, Oct 11, 2022 – (ACN Newswire) – Rock ‘n roll may be dead,…
New Wasabi partnerships with leading technology solution providers in South East Asia include OneT Solutions…
Washington, D.C., Oct 11, 2022 – (ACN Newswire) – Solve.Care (https://solve.care/), a healthcare platform company…
SALT LAKE CITY–(BUSINESS WIRE)–#robotics—Sarcos Technology and Robotics Corporation (“Sarcos”) (NASDAQ: STRC and STRCW), a leading…
Trn1 instances powered by AWS Trainium chips deliver the highest performance on deep learning training…
Memorandum of understanding also includes the exploration of new products in ESG, ETFs and digital…
SAN JOSE, Calif.–(BUSINESS WIRE)–Western Digital Corp. (NASDAQ: WDC) plans to announce its first quarter fiscal…
DALLAS–(BUSINESS WIRE)–Flowserve Corporation (NYSE: FLS), a leading provider of flow control products and services for…
SANTA MONICA, Calif.–(BUSINESS WIRE)–BlackRock TCP Capital Corp. (NASDAQ: TCPC) announced today that it will report…
HOPKINS, Minn.–(BUSINESS WIRE)–Digi International® Inc. (NASDAQ: DGII) will release its financial results in a shareholder…
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Informatica (NYSE: INFA), an enterprise cloud data management leader, today announced it…
Opportunities are available for several areas of the company in different regions of the United…
Carvana adds co-signer financing option to qualified Baltimore applicants PHOENIX–(BUSINESS WIRE)–Carvana (NYSE: CVNA) the industry…
Customers Can Now Easily Add a Cosigner When Financing With Carvana PHOENIX–(BUSINESS WIRE)–Carvana (NYSE: CVNA)…
Fast-Track Grant will support ongoing preclinical development of a Vasculogenic Mimicry-blocking Antibody Fusion therapeutic for Triple…
PRESS RELEASE AB SCIENCE RECEIVES FIRST AGENCIES AUTHORIZATIONS TO INITIATE CONFIRMATORY PHASE 3 CLINICAL STUDY…